Direct‐acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Direct‐acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta‐analysis

Published:2019-01-21 Issue:2 Volume:21 Page:e13047
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Liu Jiaye¹²,Ma Buyun²,Cao Wanlu²,Li Meng²,Bramer Wichor M.³,Peppelenbosch Maikel P.²,Pan Qiuwei¹²^ORCID

Affiliation:

1. Biomedical Research Center Northwest Minzu University Lanzhou China

2. Erasmus MC Cancer Institute Erasmus MC‐University Medical Center Rotterdam The Netherlands

3. Department of Medical Library Erasmus MC‐University Medical Center Rotterdam The Netherlands

Funder

KWF Kankerbestrijding

China Scholarship Council

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13047

Reference56 articles.

1. Hepatitis C and liver transplantation

2. Long-Term Outcome of Hepatitis C Infection after Liver Transplantation

3. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients

5. Directly Acting Antivirals (DAAs) for the Treatment of Chronic Hepatitis C Virus Infection in Liver Transplant Patients: “A Flood of Opportunity”

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating the global prevalence of secondary hyperparathyroidism in patients with chronic kidney disease;Frontiers in Endocrinology;2024-06-21

2. Biliary atresia and liver transplantation in the United States: A contemporary analysis;Liver International;2023-08-07

3. Changing Landscape of Liver Transplantation in the Post-DAA and Contemporary ART Era;Life;2022-11-01

4. Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis;Chinese Medical Journal;2022-07-20

5. Are Hepatitis C Positive Female Liver Transplant Recipients Still at Increased Risk for Graft Failure? Reexamining the Disparity in the Modern Era of Direct-acting Antiviral Agents;Transplantation;2021-12-13